China, Finland To Set Up Pharmaceutical Industry Fund
This article was originally published in PharmAsia News
Executive Summary
Finland and China investors will jointly set up a €30 million industry fund that exclusively invests in early-stage development of China's biopharmaceutical projects and supports their internationalization. Finnish Industry Investment Ltd., part of Finland's Ministry of Trade and Industry, will assume most of the country's €15 million investment with private capital making up the rest. Three Chinese private investors are in discussions and the Finns hope to secure government interest as well. The fund is also part of Finland's biotech health project that seeks collaboration with China's universities in R&D and offers services for Chinese products entering Europe. However, analysts point out that no proper exit strategy is in place, which could deter investors' participation. (Click here for more - Chinese Language)
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.